Skip to main content

Advertisement

Log in

Aggressive early surgical strategy in patients with intracranial hemorrhage: a new cardiopulmonary bypass option

  • Original Article
  • Published:
General Thoracic and Cardiovascular Surgery Aims and scope Submit manuscript

Abstract

Objective

We present a novel strategy in cardiac surgery with a cardiopulmonary bypass with low-dose heparin and Nafamostat mesylate as an anticoagulant (NM-CPB), which reduces postoperative neurological complications.

Method and results

19 patients with a mean age of 63.6 ± 20.2 years (range 24–91) and an indication of early cardiac surgery with intracranial complication (ICC) underwent surgery with NM-CPB. The preoperative diagnoses included seven cases of infective endocarditis and six of left atrial appendage thrombosis. ICC were noticed in seven cases with hemorrhages (hemorrhagic infarction: n = 4, subarachnoid hemorrhage: n = 3) and 12 without hemorrhage (large infarction: n = 10, small-multiple infarction at the risk for hemorrhagic transformation: n = 2). The mean interval between a diagnosis and cardiac surgery was 1.1 ± 1.5 days in the ICH cases and 1.4 ± 1.4 days otherwise.

In-hospital mortality was 5.3%. The mean CPB time was 146.7 ± 66.03 min, the mean dose of NM, heparin were 2.23 ± 1.59 mg/kg/hr and 56.8 ± 20.3 IU/kg, respectively. The mean activated clotting time (ACT) was 426.8 ± 112.4 s. No further intracranial bleeding and no new hemorrhages were observed after surgery.

Conclusions

In early cardiac surgery with ICC, especially with hemorrhage, NM-CPB reduced postoperative neurological complications. We plan to use NM-CPB to expand the indications and to establish an early aggressive treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al. 2015 ESC Guidelines for the management of infective endocarditis. Eur Heart J. 2015;36(44):3075–128.

    Article  Google Scholar 

  2. Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(7):2160–226.

    Article  Google Scholar 

  3. Nakamura M, Uzuka T, Sato H, Kondo M, Sakta J, Kodama F. Early surgery with aggressive surgical approach to improve 6-month outcomes in patients with active infective endocarditis: contribution of cerebral preoperative magnetic resonance imaging. Gen Thorac Cardiovasc Surg. 2019;67(5):427–35.

    Article  Google Scholar 

  4. Hitomi Y, Ikari N, Fujii S. Inhibitory effect of a new synthetic protease inhibitor (FUT-175) on the coagulation system. Haemostasis. 1985;15(3):164–8.

    CAS  PubMed  Google Scholar 

  5. Sakamoto T, Kano H, Miyahara S, Inoue T, Izawa N, Gotake Y. Efficacy of nafamostat mesilate as anticoagulation during cardiopulmonary bypass for early surgery in patients with active infective endocarditis complicated by stroke. J Heart Valve Dis. 2014;23(6):744–51.

    PubMed  Google Scholar 

  6. Ota T, Okada K, Kano H, Okita Y. Cardiopulmonary bypass using nafamostat mesilate for patients with infective endocarditis and recent intracranial hemorrhage. Interact Cardiovasc Thoracic Surg. 2007;6(3):270–3.

    Article  Google Scholar 

  7. Miura T, Eishi K. Current treatment of active infective endocarditis with brain complications. Gen Thorac Cardiovasc Surg. 2013;61(10):551–9.

    Article  Google Scholar 

  8. Hosono M, Sasaki Y, Hirai H, et al. Considerations in timing of surgical intervention for infective endocarditis with cerebrovascular complications. J Heart Valve Dis. 2010;19(3):321–5.

    PubMed  Google Scholar 

  9. Shang E, Forrest GN, Chizmar T, Chim J, Brown JM, Zhan M. Mitral valve infective endocarditis: benefit of early operation and aggressive use of repair. Ann Thorac Surg. 2009;87(6):1728–34.

    Article  Google Scholar 

  10. Eishi K, Kawazoe K, Kuriyama Y, Kitoh Y, Kawashima Y, Omae T. Surgical management of infective endocarditis associated with cerebral complications. Multi-center retrospective study in Japan. J Thorac Cardiovasc Surg. 1995;110(6):1745–55.

    Article  CAS  Google Scholar 

  11. Nakatani S, Ohara T, Ashihara K, et al. JCS 2017 guideline on prevention and treatment of infective endocarditis. Circ J. 2019;83(8):1767–809.

    Article  Google Scholar 

  12. Pettersson GB, Coselli JS, Pettersson GB, Coselli JS, Hussain ST, Griffin B, et al. 2016 The American Association for Thoracic Surgery (AATS) consensus guidelines: surgical treatment of infective endocarditis: executive summary. J Thorac Cardiovasc Surg. 2017;153(6):1241–58.

    Article  Google Scholar 

  13. Baddour LM, Wilson WR, Bayer AS, Fowler VG, Tleyjeh IM, Rybak MJ. Infective endocarditis in adults: Diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015;132(15):1435–86.

    Article  CAS  Google Scholar 

  14. García-Cabrera E, Fernández-Hidalgo N, Almirante B, Ivanova-Georgieva R, Noureddine M, Plata A. Neurological complications of infective endocarditis risk factors, outcome, and impact of cardiac surgery: a multicenter observational study. Circulation. 2013;127(23):2272–84.

    Article  Google Scholar 

  15. Ruttmann E, Willeit J, Ulmer H, Chevtchik O, Höfer D, Poewe W. Neurological outcome of septic cardioembolic stroke after infective endocarditis. Stroke. 2006;37(8):2094–9.

    Article  Google Scholar 

  16. Okita Y, Minakata K, Yasuno S, Uozumi R, Sato T, Ueshima K, et al. Optimal timing of surgery for active infective endocarditis with cerebral complications: A Japanese multicentre study. Eur J Cardiothorac Surg. 2016;50(2):374–82.

    Article  Google Scholar 

  17. Saito S, Shindo S, Tsudaka S, Uchida K, Shirakawa M, Yoshimura S. Resolving thrombus in the left atrial appendage by edoxaban treatment after acute ischemic stroke: report of 2 cases. J Stroke Cerebrovasc Dis. 2016;25(10):e188–91.

    Article  Google Scholar 

  18. Saito S, Tomita H, Kimura Y, Shiroto H, Hagii J, Metoki N, et al. Reduced smoke-like echo and resolved thrombus in the left atrium with rivaroxaban therapy in an acute cardioembolic stroke patient. J Stroke Cerebrovasc Dis. 2014;23(6):1747–9.

    Article  Google Scholar 

  19. Yasaka M, Yamaguchi T, Miyashita T, Tsuchiya T. Regression of intracardiac thrombus after embolic stroke. Stroke. 1990;21(11):1540–4.

    Article  CAS  Google Scholar 

  20. Fang BR, Kuo LT. Recurrent cerebral embolism and impending detachment of a previous nonmobile left atrial thrombus following initiation of anticoagulant therapy in a patient with nonvalvular atrial fibrillation. Echocardiography. 2001;18(6):527–9.

    Article  CAS  Google Scholar 

  21. Tabata E, Yasaka M, Wakugawa Y, Komori M, Mori K, Tsurusaki Y, et al. Increase in the size of an intracardiac thrombus during dabigatran therapy (110 mg b.i.d.) in an acute cardioembolic stroke patient. Cerebrovasc Dis Extra. 2013;3(1):78–80.

    Article  Google Scholar 

  22. Yamamoto S. Left atrial myxoma surgically resected in acute phase of hemorrhagic cerebral infarction: report of a case. Kyobu Geka. 2007;60(3):237–41.

    PubMed  Google Scholar 

  23. Yasuda S, Tokunaga S, Matsuki Y, Okamoto H, Machida D, Masuda M. Left atrium ball thrombus in a patient with hemorrhagic cerebral infarction. Ann Thorac Surg. 2013;96(6):2236–8.

    Article  Google Scholar 

  24. Despotis GJ, Gravlee G, Filos K, Levy J. Anticoagulation monitoring during cardiac surgery: a review of current and emerging techniques. Anesthesiology. 1999;91:1122–51.

    Article  CAS  Google Scholar 

  25. Miyamoato Y, Nakano S, Kaneko M, Takano H, Matsuda H. Clinical evaluation of a new synthetic protease inhibitor in open heart surgery effect on plasma serotonin and histamine release and blood conservation. ASAIO J. 1992;38(3):395–8.

    Article  Google Scholar 

  26. Tanaka K, Takao M, Yada I, Yusas M, Kusagawa M, Deguchi K. Alterations in coagulation and fibrinolysis associated with cardiopulmonary bypass during open heart surgery. J Cardiothorac Anesth. 1989;3(2):181–8.

    Article  CAS  Google Scholar 

  27. Sato S, Tanaka K, Kondo C, Morimoto T, Yada I, Yuasa H, et al. Nafamostat mesilate administration during cardiopulmonary bypass decreases postoperative bleeding after cardiac surgery. ASAIO Trans. 1991;37(3):194–5.

    Google Scholar 

  28. Tanaka K, Kondo C, Takagi K. Effects of nafamostat mesilate on platelets and coagulofibrinolysis during cardiopulmonary bypass surgery. ASAIO J. 1993;39(3):545–9.

    Google Scholar 

  29. Murase M, Usui A, Tomita Y, Maeda M, Koyama T, Abe T. Nafamostat mesilate reduces blood loss during open heart surgery. Circulation. 1993;88(5):432–6.

    Google Scholar 

  30. Fukata Y. Reduction in dose of heparin by combined use of nafamostat mesilate for the control of cardiopulmonary bypass. Iryo. 1994;48(3):196–201.

    Google Scholar 

Download references

Acknowledgements

The authors would like to thank Prof. Emeritus Yutaka Okita and the department of cardiovascular surgery Kobe University for their kind guidance and continuous support.

Funding

The authors declare no grants, and sources of funding related to the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Takahiro Yamazato.

Ethics declarations

Conflict of interest

The authors declare no conflicts of interest related to the manuscript.

Institutional review board approval

All procedures used in this research were approved by the Ethical Committee of Okinawa Nanbu Prefectural Medical Center and Childrenʼs Medical Center, (No 22, Jun 29, 2017).

Informed consent

Written informed consent was obtained from the patient for publication of this article and accompanying images.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yamazato, T., Oyama, N., Fujii, T. et al. Aggressive early surgical strategy in patients with intracranial hemorrhage: a new cardiopulmonary bypass option. Gen Thorac Cardiovasc Surg 70, 602–610 (2022). https://doi.org/10.1007/s11748-021-01743-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11748-021-01743-w

Keywords

Navigation